Drug Research

Immune Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to bertilimumab for the treatment of bullous pemphigoid (BP).…
Read More...

Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration (FDA).…
Read More...

Eisai Inc. and Merck, known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA …
Read More...

BioNTech AG announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. to develop mRNA-based vaccines for prevention of influenza…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson confirmed positive topline results from the global, Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS)…
Read More...

Onspira Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational product, OSP-101, for the treatment of…
Read More...

Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing a first-in-class platform of novel therapeutic compounds for the treatment of diseases…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair (omalizumab) for the prevention of severe allergic reactions…
Read More...

Medicure Inc. announced that the United States Food and Drug Administration has approved its Abbreviated New Drug Application for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL)…
Read More...

Teneobio and Poseida Therapeutics announced a new research collaboration and licensing agreement to develop novel CAR-T therapies using Teneobio’s heavy chain only domain antibodies…
Read More...

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen, an SME focused on the development…
Read More...

Regeneron Pharmaceuticals, Inc. and bluebird bio, Inc. announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has extended its strategic research collaboration with the Rheumatology Unit…
Read More...

Antares Pharma, Inc. announced that it has entered into an agreement with Pfizer Inc. to develop a combination drug device rescue pen. This rescue pen will utilize the Antares QuickShot…
Read More...

Alteogen Inc. announced that it has successfully got an approval for orphan drug designation from the US Food and Drug Administration (FDA) with one of its assets (ALT-P7) for gastric…
Read More...

AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside the US and Canada) announced that the European Medicines Agency (EMA) has granted orphan designation to…
Read More...

Takeda Pharmaceutical Company Limited announced the opening of a production site for NINLARO (ixazomib), an innovative drug for patients with multiple myeloma, at its Yaroslavl plant.…
Read More...

Puma Biotechnology announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for the medicinal product NERLYNX (neratinib) for the extended adjuvant…
Read More...

HiFiBiO Therapeutics announced a multi-target agreement with Takeda Pharmaceutical Company Limited (Takeda) to enable the discovery of breakthrough antibody therapies to potentially…
Read More...

Nektar Therapeutics announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review the company's New Drug Application (NDA) for NKTR-181 for the treatment…
Read More...